Scientists are developing protection for that risky period until their new immune system kicks in — injections of cells specially designed to fend off up to five different viruses at once.
Porcine epidemic diarrhea has killed millions of baby pigs since it showed up in the United States last year, and pork prices have been rising for months. For consumers, the worst may be yet to come because the most deaths happened last winter.
FDA regulators want companies to consult with them before launching nanotechnology products, though the decision whether to go to market will essentially rest with manufacturers.
Women with heart failure are less likely to get a special kind of pacemaker than men, but more likely to benefit from the device, a government analysis suggests.
Leading medical societies recommend the drug as a first-line treatment, and patients are clamoring for it, but insurance companies and state Medicaid programs are gagging on the price.
U.S. medical device manufacturer Medtronic announced Sunday night that it has agreed to buy Ireland-based competitor Covidien for $42.9 billion in cash and stock.
The American Medical Association is pledging to use its lobbying power to seek strict limits on electronic cigarettes.
By 2018, robots are projected to be used for 27 percent of new line installations for medical device primary packaging — compared to just 3 percent in 2013.
The New Markets Tax Credit (NMTC) Program, established back in 2000 to spur economic development in blighted communities around the U.S., actually doesn’t exist anymore. But if the story of Mölnlycke Health Care and Brunswick, Maine, means anything, it's that the tax credit is about due to be revived.
Siemens, based in Germany, is donating the same software the company and its clients use in the automotive, aerospace, consumer products, medical device, electronics, shipbuilding and apparel industries.
Britain's fertility regulator says controversial techniques to create embryos from the DNA of three people "do not appear to be unsafe" even though no one has ever received the treatment, according to a new report.
A German museum has put on display a copy of Vincent van Gogh's ear that was grown using some of the Dutch artist's genetic material.
A federal jury has convicted the former top two executives of a Texas medical device company for taking part in a scheme that defrauded shareholders and investors out of more than $400 million.
Makers of sun lamps and related devices must include a bold label, known as a black box warning stating that they should not be used by people under age 18.
The Food and Drug Administration has approved a new implantable device to help doctors monitor patients with severe heart failure as they go about their day.
Nine scientists won awards Thursday for theories about the first moments of the universe, discoveries about the brain and techniques to let researchers see ever-tinier things.
Doctors in Italy have designed a miniature dialysis machine for babies, used for the first time last year to save a newborn girl, according to a new report.
Medtronic has agreed to pay more than $1 billion to settle long-standing patent litigation with fellow medical device maker Edwards Lifesciences over replacement heart valves.
Britain is offering almost $17 million to whoever can solve one of humanity's biggest scientific challenges — once the public has decided what it is.
Germany's Bayer AG says it's selling its interventional division to the Boston Scientific Corporation for $415 million so that it can focus on growth in other areas.
Suman traveled to New York to tape the show's regular segment called "Fallonventions," which showcases the achievements of young inventors. He used his Steth IO, which turns a smartphone into a stethoscope, to listen to Fallon's heart.
Medical device maker Boston Scientific said Thursday the U.S. government wants documents related to its Cognis and Teligen heart devices.
Scientists implanted thin sheets of scaffolding-like material from pigs into a few young men with disabling leg injuries — and say the experimental treatment coaxed the men's own stem cells to regrow new muscle.
Drug and medical device maker says it will pay $830 million to resolve roughly 20,000 personal lawsuits from patients who say they were injured by the company's vaginal mesh implants.